CT Camp4 Therapeutics Corp Stock: price and insider trades · United States · SEC (Form 4)Track the Camp4 Therapeutics Corp stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €260.4m. The latest transaction was filed on 31 August 2026 (Cession). Among the most active insiders: Schwab Andrew J.. All data is free.
Analyst consensus: bullish or bearish? Analysts rate Camp4 Therapeutics Corp Strong Buy (bullish), based on 6 analysts. Average price target: US$9.92.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
All Executives31 Thresholds0 Prospectus0 Other0
Declarations 31 total
▼ Director · Executives · 27 Aug 2026
400,000 shares @ US$4.04 Common Stock SEC:0001598549-26-000011:0
▼ Director · Executives · 24 Aug 2026
10 shares @ US$4.50 0.0000% mcap 0.0% of flow Common Stock SEC:0001598549-26-000009:0
▼ Director · Executives · 19 Aug 2026
45,147 shares @ US$4.76 0.071% mcap 4.0% of flow Common Stock SEC:0001598549-26-000007:0
▼ Director · Executives · 20 Aug 2026
114,700 shares @ US$4.54 0.17% mcap 9.7% of flow Common Stock SEC:0001598549-26-000007:1
▼ Director · Executives · 21 Aug 2026
32,018 shares @ US$4.50 0.047% mcap 2.7% of flow Common Stock SEC:0001598549-26-000007:2
▼ Chief Scientific Officer · Executives · 19 Aug 2026
1,738 shares @ US$4.76 0.0027% mcap 100.0% of flow Common Stock SEC:0001628280-26-058107:0
▲ Chief Medical Officer · Executives · 3 Aug 2026
6,551 shares @ US$1.65 0.0036% mcap 52.4% of flow Common Stock SEC:0001628280-26-053512:0
Canonical exit: 1 Nov 2026 (T+90) ▲ Director · Executives · 3 Aug 2026
16,378 shares @ US$1.65 0.0089% mcap 52.4% of flow Common Stock SEC:0001628280-26-053513:0
Canonical exit: 1 Nov 2026 (T+90) ▲ Chief Executive Officer · Executives · 3 Aug 2026
6,551 shares @ US$1.65 0.0036% mcap 52.4% of flow Common Stock SEC:0001628280-26-053505:0
Canonical exit: 1 Nov 2026 (T+90) ▲ Chief Financial Officer · Executives · 3 Aug 2026
6,551 shares @ US$1.65 0.0036% mcap 52.4% of flow Common Stock SEC:0001628280-26-053511:0
Canonical exit: 1 Nov 2026 (T+90) ◆ Director · Executives · 11 Sept 2025
2,941,176 shares @ US$1.53 100.0% of flow Common Stock SEC:0001598549-25-000004:0
2,941,176 shares @ US$1.53 29.4% of flow Common Stock SEC:0001231919-25-000196:0
Canonical exit: 10 Dec 2025 (T+90) ▲ Chief Financial Officer · Executives · 11 Sept 2025
6,060 shares @ US$1.65 100.0% of flow Common Stock SEC:0002033333-25-000003:0
Canonical exit: 10 Dec 2025 (T+90) ▲ Chief Executive Officer · Executives · 11 Sept 2025
6,060 shares @ US$1.65 100.0% of flow Common Stock SEC:0001927058-25-000002:0
Canonical exit: 10 Dec 2025 (T+90) ▲ Chief Medical Officer · Executives · 11 Sept 2025
6,060 shares @ US$1.65 100.0% of flow Common Stock SEC:0001881045-25-000003:0
Canonical exit: 10 Dec 2025 (T+90) ▲ Director · Executives · 11 Sept 2025
15,151 shares @ US$1.65 100.0% of flow Common Stock SEC:0001490283-25-000003:0
Canonical exit: 10 Dec 2025 (T+90) 1,221,721 shares @ US$1.53 100.0% of flow Common Stock SEC:0001193125-25-201392:0
Canonical exit: 10 Dec 2025 (T+90) ▲ Director · Executives · 11 Sept 2025
1,221,721 shares @ US$1.53 100.0% of flow Common Stock SEC:0001193125-25-201380:0
Canonical exit: 10 Dec 2025 (T+90) 1,250,061 shares Common Stock SEC:0000950170-24-116360:0
1,398,067 shares Common Stock SEC:0001415889-24-025380:0
2,422,166 shares Common Stock SEC:0001415889-24-025354:0
1,003,193 shares Common Stock SEC:0001415889-24-025393:0
1,250,061 shares Common Stock SEC:0000950170-24-114788:0
1,716,055 shares Common Stock SEC:0001415889-24-025140:0
● Director · Executives · 15 Oct 2024
1,337,592 shares Common Stock SEC:0001104659-24-108702:0
25 of 31 declarations
Load more (6 remaining) 关于 Camp4 Therapeutics Corp Camp4 Therapeutics Corp 是一家专注于开发遗传疾病创新疗法的公司。它采用基因组编辑方法来创建治疗解决方案。